Not Tagged
vjoncology
['rectal', 'vjoncology']
neoadjuvant folfox, with only selective use of pelvic chemoradiation, is a safe and effective treatment option for patients with ct2n+, c3n-, or c t3n+ rectal cancer #asco2023 #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.